| Panjon Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 526345 |
NSE Symbol : - |
P/E(TTM) : 347.91 |
|
ISIN Demat : INE744D01019 |
Div & Yield% : - |
EPS(TTM) : 0.11 |
|
Book Value(₹) : 8.96 |
Market Cap(₹Cr) : 65.69 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 3.38 | 2.09 | 5.20 | 4.81 | 1.30 | 1.24 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3.38 | 2.09 | 5.20 | 4.81 | 1.30 | 1.24 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.08 | 0.10 | 0.27 | 0.06 | 0.04 | 0.08 |
| Total Income | 3.46 | 2.19 | 5.48 | 4.87 | 1.34 | 1.32 |
| Total Expenditure | 3.31 | 2.08 | 5.24 | 4.81 | 1.27 | 1.28 |
| PBIDT | 0.15 | 0.11 | 0.23 | 0.07 | 0.07 | 0.04 |
| Interest | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| PBDT | 0.12 | 0.09 | 0.22 | 0.06 | 0.06 | 0.04 |
| Depreciation | 0.05 | 0.05 | 0.16 | 0.02 | 0.02 | 0.02 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.07 | 0.03 | 0.05 | 0.04 | 0.04 | 0.02 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.07 | 0.03 | 0.05 | 0.04 | 0.04 | 0.02 |
| EPS (Unit Curr.) | 0.04 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 |
| EPS (Adj) (Unit Curr.) | 0.04 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 |
| Calculated EPS (Unit Curr.) | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 |
| Calculated EPS (Adj) (Unit Curr.) | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.16 | 0.08 | 0.13 | 0.11 | 0.10 | 0.06 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.16 | 0.08 | 0.13 | 0.11 | 0.10 | 0.06 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.31 | 16.31 | 16.31 | 15.50 | 15.50 | 15.50 |
| Reserve & Surplus | -1.46 | -1.46 | -1.46 | 1.00 | -2.57 | 1.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 4.44 | 5.26 | 4.42 | 1.46 | 5.38 | 3.23 |
| PBDTM(%) | 3.55 | 4.31 | 4.23 | 1.25 | 4.62 | 3.23 |
| PATM(%) | 2.07 | 1.44 | 0.96 | 0.83 | 3.08 | 1.61 |